- Ukwelashwa
- Ubufakazi
- I-Neuroblastoma
- Isimila Esiqinile
- Ubufakazi
- I-TILS
- Ukwelashwa Kwamaseli e-NK
- I-Myasthenia Gravis (MG)
- I-Acute Lymphoblastic Leukemia (B-ALL)
- I-Systemic Lupus Erythematosus (SLE)
- I-Acute Lymphoblastic Leukemia (T-ALL)
- I-Non-Hodgkin Lymphoma (NHL)
- I-Multiple Myeloma (MM)
- I-Diffuse Large B-cell Lymphom
- I-B-lymphocytic Leukemia
- I-Myeloma
I-Acute Lymphoblastic Leukemia (T-ALL)-03
Izici Zecala:
- Ukuxilongwa: I-Acute T-cell lymphoblastic leukemia
- Ukuqala kanye Nezimpawu: Ephreli 2020, kwavela isiyezi, ukukhathala, kanye namaphuzu okopha esikhumbeni. Kutholakale ukuthi une-acute T-cell lymphoblastic leukemia ngokuhlolwa kwe-bone marrow MICM.
- Ukwelashwa Kokuqala: Uthole ukuxolelwa okuphelele (CR) ngemuva kokwelashwa ngamakhemikhali kwe-VDCLP, kulandelwa imijikelezo emibili yokwelashwa ngamakhemikhali okuqinisiwe.
- Julayi 19, 2020: Kwatholwa ukufakelwa kwe-allogeneic hematopoietic stem cell kusuka kumnikeli wesifazane (HLA 5/10 A donor A). Uhlelo lokulungisa isimo luhlanganisa ukushiswa komzimba wonke (TBI), i-cyclophosphamide (CY), kanye ne-etoposide (VP-16). Amaseli e-peripheral stem afakwa ngoJulayi 24, kanye nokululama kwe-granulocyte ngosuku +10 kanye nokuxhunyelelwa kwama-platelet ngosuku +13. Ukulandelela njalo kweziguli zangaphandle ngemva kwalokho.
- 25 Nhlolanja 2021: Kutholakale ukuphinda kubuye umnkantsha ngesikhathi sokulandelela.
- Ukwelashwa: Ngaqala ukwelashwa nge-thalidomide ngomlomo.
- Mashi 8: Ungeniswe esibhedlela sethu.
- Ukwakheka kwe-Bone Marrow: ukuqhuma okungu-61.5%.
- Ukuhlukaniswa Kwegazi Okungaphandle: ukuqhuma okungu-15%.
- I-Immunophenotyping: amaseli angu-35.25% aveza i-CD99, i-CD5, i-CD3dim, i-CD8dim, i-CD7, i-cCD3, i-CD2dim, i-HLA-ABC, i-cbcl-2, i-CD81, i-CD38, okubonisa ama-T lymphocyte angakavuthwa ayingozi.
- Ukuhlaziywa kwe-Chromosome: 46, XX [9].
- I-Leukemia Fusion Gene: I-SIL-TAL1 fusion gene positive; isilinganiso sobuningi: I-SIL-TA.
- Ukuguquka Kwesimila Segazi: Okubi.
- Ukuhlaziywa kwe-Chimerism (ngemuva kwe-HSCT): Amaseli atholakala kubanikeli abalelwa ku-45.78%.
- Mashi 11: Ukuqoqwa kwama-lymphocyte egazi angaphandle kwe-autologous ukuze kukhuliswe amangqamuzana e-CD7-CART.
- Ukwelashwa: I-VILP (VDS 4mg, IDA 10mg, L-asparaginase 10,000 IU qd x izinsuku ezi-4, Dex 9mg q12h x izinsuku eziyi-9) ehlanganiswe ne-thalidomide ukulawula isimila.
- Mashi 19: Ukwelashwa ngamakhemikhali kwe-FC (Umkhuhlane 50mg x izinsuku ezi-3, i-CTX 0.4gx izinsuku ezi-3).
- Mashi 24 (ngaphambi kokufakwa): Ukwakheka komnkantsha wethambo kubonise i-grade V hyperplasia, kanye nokuqhuma okungu-22%.
- I-Bone Marrow Flow Cytometry: amaseli angu-29.21% (amaseli ane-nucleated) aveza i-CD3, i-CD5, i-CD7, i-CD99, aveza i-cCD3 ngokwengxenye, okubonisa amaseli e-T angakavuthwa ayingozi.
- I-Quantitative SIL-TAL1 Fusion Gene: 1.913%.
incazelo2
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

